As of 2025-01-14, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 39.75 USD. This relative valuation is based on P/E multiples. With the latest stock price at 66.99 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -40.7%.
The range of the Relative Valuation is 26.33 - 56.75 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.7x - 33.6x | 30.6x |
| Forward P/E multiples | 23.5x - 40.1x | 24.8x |
| Fair Price | 26.33 - 56.75 | 39.75 |
| Upside | -60.7% - -15.3% | -40.7% |
| Date | P/E |
| 2025-01-13 | 39.61 |
| 2025-01-10 | 39.84 |
| 2025-01-08 | 40.44 |
| 2025-01-07 | 40.15 |
| 2025-01-06 | 39.66 |
| 2025-01-03 | 39.52 |
| 2025-01-02 | 39.32 |
| 2024-12-31 | 38.87 |
| 2024-12-30 | 38.70 |
| 2024-12-27 | 39.55 |
| 2024-12-26 | 39.63 |
| 2024-12-24 | 39.40 |
| 2024-12-23 | 39.19 |
| 2024-12-20 | 38.83 |
| 2024-12-19 | 38.44 |
| 2024-12-18 | 38.25 |
| 2024-12-17 | 39.73 |
| 2024-12-16 | 38.76 |
| 2024-12-13 | 39.03 |
| 2024-12-12 | 39.18 |
| 2024-12-11 | 39.01 |
| 2024-12-10 | 39.28 |
| 2024-12-09 | 39.51 |
| 2024-12-06 | 39.47 |
| 2024-12-05 | 39.12 |
| 2024-12-04 | 39.33 |
| 2024-12-03 | 37.37 |
| 2024-12-02 | 38.46 |
| 2024-11-29 | 39.05 |
| 2024-11-27 | 38.68 |
| 2024-11-26 | 38.37 |
| 2024-11-25 | 38.49 |
| 2024-11-22 | 38.00 |
| 2024-11-21 | 37.52 |
| 2024-11-20 | 36.99 |
| 2024-11-19 | 36.64 |
| 2024-11-18 | 36.62 |
| 2024-11-15 | 37.50 |
| 2024-11-14 | 38.79 |
| 2024-11-13 | 39.42 |
| 2024-11-12 | 39.10 |
| 2024-11-11 | 39.25 |
| 2024-11-08 | 39.66 |
| 2024-11-07 | 39.58 |
| 2024-11-06 | 39.12 |
| 2024-11-05 | 39.05 |
| 2024-11-04 | 39.03 |
| 2024-11-01 | 39.38 |
| 2024-10-31 | 38.96 |
| 2024-10-30 | 39.43 |